| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 03/06/2013 | CN102952178A Preparation method for high-purity echinocandin compound |
| 03/06/2013 | CN102952177A Odorrana tiannanensis natural antioxidant peptide reconstructed body and preparation method and application thereof |
| 03/06/2013 | CN102952176A Bioactive polypeptide for promoting osteogenic growth and preparation method thereof |
| 03/06/2013 | CN102952175A Method for preparing somatostatin through solid-phase peptide synthesis |
| 03/06/2013 | CN102952174A Method for synthesizing degarelix |
| 03/06/2013 | CN102952173A Preparation method of new polypeptide with tissue protection activity and application in treatment of bovine mastitis |
| 03/06/2013 | CN102250216B Rana nigromaculata antimicrobial peptide as well as gene and application thereof |
| 03/06/2013 | CN102174083B Compositae cyclopeptide, immunosuppressive medicine using compositae cyclopeptide as active ingredient and preparation method and application of compositae cyclopeptide |
| 03/06/2013 | CN102115492B Vascular endothelial growth factor receptor partial polypeptide and application thereof |
| 03/06/2013 | CN101863960B Preparation method of cetrorelix |
| 03/05/2013 | US8389791 Treatment devices and methods with extending elements |
| 03/05/2013 | US8389481 Glutamate-enhanced cell-penetrating peptides and methods of using same |
| 02/28/2013 | WO2013028843A1 Peptide nanoparticles and uses thereof |
| 02/28/2013 | WO2013027796A1 IgG-BINDING PEPTIDE AND METHOD FOR DETECTING AND PURIFYING IgG USING SAME |
| 02/28/2013 | WO2013026927A1 Potent ligands of the ghrelin receptor |
| 02/28/2013 | WO2013026334A1 Cell dna synthesis prevention and cell proliferation inhibition polypeptide and use thereof |
| 02/28/2013 | WO2013026157A1 Anti-cancer peptides and uses thereof |
| 02/28/2013 | WO2013026089A1 Peptides for use in the treatment of il-1 related diseases and conditions |
| 02/28/2013 | WO2013000922A9 Ccr2 antagonist peptides |
| 02/28/2013 | WO2012159006A3 Polypeptides and vectors for targeting her2/neu expressing cells and uses thereof |
| 02/28/2013 | WO2012158960A3 Melanocortin 1 receptor ligands and methods of use |
| 02/28/2013 | WO2012123495A3 Functionalized biomaterials for tissue regeneration |
| 02/28/2013 | US20130053330 Fertilization Prediction and Promotion |
| 02/28/2013 | US20130053327 Polypeptide expressed in the stratum corneum and use thereof |
| 02/28/2013 | US20130053324 Novel self-assembling peptides and their use in the formation of hydrogels |
| 02/28/2013 | US20130053323 Methods and use related to humanin and humanin-like peptides |
| 02/28/2013 | US20130053321 Inhibitors of mitochondrial fission and methods of use thereof |
| 02/28/2013 | US20130053305 Peptide compounds that can be used as antibacterial agents |
| 02/28/2013 | US20130052667 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 02/28/2013 | US20130052654 Amyloid Precursor Protein E2 Domain and Uses Thereof |
| 02/28/2013 | US20130052214 Identification of a peptide(s) that induces autoimmune anterior uveitis |
| 02/28/2013 | US20130052172 Methods for diagnosing and treating cardiac defects |
| 02/28/2013 | DE102011111991A1 Neue Cyclosporin-Derivate New cyclosporin derivatives |
| 02/28/2013 | CA2845886A1 Peptide nanoparticles and uses thereof |
| 02/27/2013 | EP2562181A1 Potent ligands of the ghrelin receptor |
| 02/27/2013 | EP2560690A1 Cyclopentapeptide derivatives and uses thereof |
| 02/27/2013 | CN102947327A Purification of caspofungin intermediates |
| 02/27/2013 | CN102947326A Ccn3 peptides and analogs thereof for therapeutic use |
| 02/27/2013 | CN102947325A Cdca5 peptides and vaccines including the same |
| 02/27/2013 | CN102947324A Peptide domains that bind small molecules of industrial significance |
| 02/27/2013 | CN102947323A Novel caspase-14 activator peptides and compositions comprising said peptides |
| 02/27/2013 | CN102946897A Treatment of vascular complications of diabetes |
| 02/27/2013 | CN102942617A Streptococcus suis quorum sensing system blocking peptide and application of streptococcus suis quorum sensing system blocking peptide |
| 02/27/2013 | CN102942616A Peptide capable of binding to immunoglobulin |
| 02/27/2013 | CN101955514B Method for synthesizing agarose gel hydrogen bond adsorbing chromatography medium by using quercetin as genin |
| 02/27/2013 | CN101863962B Polypeptide for inhibiting enzyme digestion of beta secretase and application thereof |
| 02/26/2013 | US8383919 Highly fluorescent peptide-metallic nanoclusters as bio-probes and methods of synthesis thereof |
| 02/26/2013 | US8383772 Ang-(1-7) receptor agonist |
| 02/26/2013 | US8383769 Peptides for inhibiting chemokine binding to chemokine receptors |
| 02/26/2013 | US8383767 Immunogenic protein carrier containing an antigen presenting cell binding domain and a cysteine-rich domain |
| 02/26/2013 | US8383593 αvβ6 peptide ligands and their uses |
| 02/26/2013 | US8383592 Apo A-I mimetic peptides and methods of treatment |
| 02/26/2013 | US8383125 Antimicrobial protein |
| 02/26/2013 | US8383108 Therapeutic uses of monoclonal antibodies to the angiotensin-II type 1 receptor |
| 02/21/2013 | WO2013025969A1 Treatments for gastrointestinal disorders |
| 02/21/2013 | WO2013025525A1 Compositions and methods for specific regulation of pyruvate dehydrogenase kinase |
| 02/21/2013 | WO2013024582A1 Mphosph1 peptides and vaccines including the same |
| 02/21/2013 | WO2013023319A1 In vitro method for modifying the depletion profile of treg cells present in a total splenocyte population of a biological sample by means of the isolation, culturing and exposure thereof to an atp and polymixin b medium |
| 02/21/2013 | WO2012172427A3 Peptide compounds for inhibition of platelet aggregation |
| 02/21/2013 | US20130046077 Dolastatin 15 derivatives |
| 02/21/2013 | US20130045928 Uses of Natriuretic Peptide Constructs |
| 02/21/2013 | US20130045922 Pro-angiogenic fragments of prominin-1 and uses thereof |
| 02/21/2013 | US20130045917 Method of selecting polypeptide sequence, and metal oxide or silicon-containing compound binding peptide and use thereof |
| 02/21/2013 | US20130045887 Peptide and protein biomarkers for type 1 diabetes mellitus |
| 02/21/2013 | US20130045490 Antibody against mucin 1 (muc1) protein and use of same |
| 02/21/2013 | US20130045191 Novel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| 02/21/2013 | CA2846230A1 Treatments for gastrointestinal disorders |
| 02/21/2013 | CA2842887A1 Mphosph1 peptides and vaccines including the same |
| 02/20/2013 | EP2559763A1 HLA-binding peptides, precursors thereof, DNA fragments and recombinant vectors that code for those peptide sequences |
| 02/20/2013 | EP2559698A2 Mutant double cyclized receptor peptides inhibiting beta 1-adrenoceptor antibodies |
| 02/20/2013 | EP2559697A1 Novel lipid peptide and hydrogel |
| 02/20/2013 | EP2559696A1 Purification method of azacyclohexapeptide or its salt |
| 02/20/2013 | CN102939301A Peptide compounds that can be used as antibacterial agents |
| 02/20/2013 | CN102936278A Epitope polypeptide of dengue virus type 2 NS3 protein and application thereof |
| 02/20/2013 | CN102936277A Human blood vessel endothelial growth factor antigen epitope and epitope vaccine thereof |
| 02/20/2013 | CN102229647B Method for synovium-derived mesenchymal stem cell affinity peptide modifying stent implanted in human body |
| 02/20/2013 | CN101724019B Thymopeptide-5 active esters, medicinal composition containing same and application thereof |
| 02/19/2013 | USRE44022 Cyclic peptides, method for preparing and use as angiogenesis inhibitors or activators |
| 02/19/2013 | US8378071 Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis |
| 02/19/2013 | US8378066 Insulinotropic peptide synthesis using solid and solution phase combination techniques |
| 02/19/2013 | US8378064 Hydrophilic polymers as medical lubricants and gels |
| 02/19/2013 | US8377890 Hair treatment agents having low-dose oligopeptides |
| 02/19/2013 | US8377885 Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
| 02/19/2013 | US8377883 Peptide for anti-angiogenesis and use thereof |
| 02/19/2013 | US8377880 Therapeutic agents for reducing parathyroid hormone levels |
| 02/19/2013 | US8377865 Growth hormone releasing peptides |
| 02/19/2013 | CA2560981C Polymer-based sustained release device |
| 02/19/2013 | CA2512780C Multivalent constructs that bind the vegf receptor-2 kdr for therapeutic and diagnostic applications |
| 02/19/2013 | CA2487137C Tumour-associated peptides that bind to mhc molecules |
| 02/19/2013 | CA2467434C Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 02/19/2013 | CA2448382C Use of hepcidin as a regulator of iron homeostasis |
| 02/14/2013 | WO2013023166A2 Hapivirins and diprovirins |
| 02/14/2013 | WO2013021284A2 Anti-il-6 vaccine composition |
| 02/14/2013 | WO2013020557A1 Method and antibodies for the identification of ubiquitinated proteins and sites of ubiquitination |
| 02/14/2013 | US20130040900 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2013 | US20130040894 Inhibition or activation of serine/threonine ulk3 kinase activity |
| 02/14/2013 | US20130040886 Peptides and Methods for Inhibiting G alpha Protein Signaling |
| 02/14/2013 | US20130040310 Ulk1 compositions, inhibitors, screening and methods of use |
| 02/14/2013 | US20130039948 Inhibition of TCR Signaling with Peptide Variants |
| 02/14/2013 | US20130039936 Immunogenic pote peptides and methods of use |